Leave Your Message

Dabrafenib Maganin Da Aka Nufi don Ciwon Ciwon Ciwon Ciwon Ciwon Ciki na BRAF

Farashin farashin: USD 50-60/kg

  • Sunan samfur Dabrafenib
  • CAS No. 1195765-45-7
  • MF Saukewa: C23H20F3N5O2S2
  • MW 519.561
  • EINECS 1592732-453-0
  • Yawan yawa 1.443
  • Wurin tafasa 653.726 °C a 760 mmHg

Cikakken Bayani

Dabrafenib shine mai hana ƙwayoyin cuta ta baki na furotin B-raf (BRAF) kuma ana amfani dashi azaman maganin ciwon daji. Yana zaɓin cutar kansar da ke da alaƙa da rikitaccen nau'in kwayar halittar BRAF. Wannan labarin ya bincika tsarin aiki, alamun asibiti, da kuma amfani da dabrafenib a cikin maganin cututtuka daban-daban.

I. Fahimtar Dabrafenib:
A. Mai hana furotin B-raf (BRAF).
B. Tsarin aiki: Toshe siginar furotin mara kyau da daidaita haɓakar tantanin halitta

17159473034104h3

II. Alamun asibiti:

A. Monotherapy:

Melanoma wanda ba a iya ganowa ko metastatic tare da maye gurbin BRAF V600E

B. Haɗuwa da maganin trametinib:

BRAF V600E-tabbatacce mara lahani ko melanoma metastatic

Metastatic marasa ƙananan ƙwayoyin huhu

Metastatic anaplastic thyroid cancer

Ciwace-ciwacen ciwace-ciwacen da ba a iya ganowa ko metastatic


III. Tsarin Aiki:

A. Zaɓin ɗauri da hanawa na B-raf

B. Hana yaduwar ƙwayar ƙwayar cuta tare da maye gurbin BRAF gene


IV. Maganin Ciwon Kansa:

A. Wani nau'in ciwon daji na thyroid wanda ya yadu zuwa kyallen jikin da ke kusa ko wasu sassan jiki

B. Juriya(s) jiyya na baya


V. Kinase Inhibitor Class:

A. Dabrafenib a matsayin memba na kinase inhibitors

B. Toshe aikin gina jiki mara kyau don hana yaduwar kwayar cutar kansa


Dabrafenib magani ne da aka yi niyya da aka yi amfani da shi a cikin maganin cutar kansar BRAF. A matsayinsa na mai hana sunadarin B-raf (BRAF), yana zaɓe yana kai hari ga ƙwayoyin ƙari waɗanda ke ɗauke da mutattacen kwayoyin halittar BRAF, yana hana haɓakarsu. Ana nuna Dabrafenib don melanoma wanda ba a iya jurewa ba ko kuma melanoma, ciwon huhu mara karami, ciwon daji na thyroid anaplastic, da ciwace-ciwacen da ba a iya jurewa ko metastatic. Haɗin magani tare da trametinib yana ƙara faɗaɗa aikace-aikacen sa. Ta hanyar fahimtar ƙayyadaddun sauye-sauyen kwayoyin halitta a cikin ƙwayoyin kansa, hanyoyin da aka yi niyya kamar dabrafenib suna taka muhimmiyar rawa wajen inganta sakamakon jiyya da hana yaduwar ƙwayoyin cutar kansa.

Ƙayyadaddun bayanai

1715947563669qd1